미국 · 보도자료 · Moleculin Biotech, Inc. · 2026-10-07 12:45
2026 맥심 성장 서밋 참여, 종양학 패널 발표 예정
HOUSTON, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. (Nasdaq: MBRX) (“Moleculin” or the “Company”) today announced that it will present at the upcoming 2026 Maxim Growth Summit in New York, NY. Details of the presentation are as follows:
